Wake Forest University School Of Medicine News

Special Studies in Cancer Patients: AME and Cardiac Safety
FierceBiotech Editor John Carroll will moderate an expert panel discussion exploring how c
Inside the mHealth Revolution with Welch Allyn: Realizing the Potential of Connected Devices
After launching a line of connected devices, Welch Allyn immediately viewed it as an oppor
Prepare Your Compliance Systems and Processes for the Physician Payments Sunshine Act
Beginning in 2012, pharmaceutical, biotechnology and medical device companies will be requ
Drug Development: An Overview of the Regulated Clinical Trials Process Used to Bring a New Drug to Market
Join us for a one-hour overview of the regulated clinical trials process used to bring a n

Most Popular Wake Forest University School Of Medicine Story

July 27, 2007 — 5:59am ET

> GSK has decided not to exercise its option to license Exelixis' non-small cell lung cancer drug XL647 for further development. Read more...

Latest Headlines